FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to a method of preparing medicinal forms containing bacteriophages, namely, bacteriophage-containing suppositorium. Method involves the combination of the purified bacteria phagolyzate with a base being a liquid phagilyzate with a titer 10-7 taken in the amount 20% of the total composition mass, not above, is added to the base. EFFECT: simplified method, increased efficiency of method. 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR SUPPURATIVE-INFLAMMATORY DISEASE TREATMENT | 1995 |
|
RU2105544C1 |
ANTIBACTERIAL COMPOSITION IN FORM OF SUPPOSITORY AND METHOD OF ITS PREPARATION | 2016 |
|
RU2622762C1 |
METHOD FOR PREPARING POLYBACTERIOPHAGE | 2002 |
|
RU2247151C2 |
BACTERIOPHAGE-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2002 |
|
RU2241446C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | 2012 |
|
RU2520346C2 |
SUPPOSITORY | 1996 |
|
RU2119330C1 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
SEXTAPHAGE (PYOBACTERIOPHAGE POLYVALENT) OR BACTERIOPHAGE SALMONELLOUS PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410084C1 |
AGENT FOR TREATMENT OF COLI INFECTION-INDUCED DISEASES | 1995 |
|
RU2104015C1 |
METHOD OF DETERMINATION OF INTERFERON ANTIVIRAL ACTIVITY IN SOFT MEDICINAL FORMS | 1995 |
|
RU2123351C1 |
Authors
Dates
2002-09-10—Published
2001-02-19—Filed